These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update. Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796 [No Abstract] [Full Text] [Related]
5. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel? Wiviott SD Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236 [TBL] [Abstract][Full Text] [Related]
6. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes. Gutierrez A; Rao SV Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248 [TBL] [Abstract][Full Text] [Related]
7. Strategies to minimize bleeding complications of percutaneous coronary intervention. White HD Curr Opin Cardiol; 2009 Jul; 24(4):273-8. PubMed ID: 19474710 [TBL] [Abstract][Full Text] [Related]
8. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Rubboli A; Halperin JL Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515 [No Abstract] [Full Text] [Related]
9. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody. Roldán V; Marín F Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516 [No Abstract] [Full Text] [Related]
10. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Willis P; Voeltz MD Am J Cardiol; 2009 Sep; 104(5 Suppl):34C-8C. PubMed ID: 19695359 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes. De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863 [TBL] [Abstract][Full Text] [Related]
12. The score is in but is the decision final? Brinker J J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596 [No Abstract] [Full Text] [Related]
13. The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk. Manoukian SV J Invasive Cardiol; 2010 Mar; 22(3):132-41. PubMed ID: 20197582 [TBL] [Abstract][Full Text] [Related]
15. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies. Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970 [TBL] [Abstract][Full Text] [Related]
16. [Coronary angioplasty in acute coronary syndromes: adjuvant drug therapy and management of the bleeding risk due to antithrombotic agents]. Zagnoni S; Casella G; Musuraca AC; Calabrese D; Pavesi PC; Di Pasquale G G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):34S-42S. PubMed ID: 21491738 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications and management of bleeding events in patients with acute coronary syndromes. De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962 [TBL] [Abstract][Full Text] [Related]